Company Overview
- Website
- ennaidthera.com
- Phone
- (678) 999-2453
- Employees
- 5
- Founded in
- 2012
- Industry
- BioTech/Drugs
- NAICS Codes
-
54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services5417 - Scientific Research and Development Services54171 - Research and Development in the Physical, Engineering, and Life Sciences541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- SIC Codes
-
87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$68B
Recent News & Media
Emergency Contraceptive Pills Market Updated Research Report 2025
- Apr 7, 2025
- insightaceanalytic.com
Nasal Vaccines Market Latest Published Study 2025-2034
- Apr 7, 2025
- insightaceanalytic.com
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
- Nov 19, 2024
- pmc.ncbi.nlm.nih.gov
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
- Feb 8, 2024
- frontiersin.org
Global Dengue Fever Pipeline Insights | Clinical Trials Evaluation Research Report 2022 by DelveInsight
- Feb 28, 2022
- globenewswire.com
Strides Pharma successfully completes EU GMP inspection of Puducherry facility
- Jun 28, 2021
- medicaldialogues.in
Who is Ennaid Therapeutics
Ennaid Therapeutics is a biotechnology company headquartered in Alpharetta, Georgia. With a team of 20 to 49 employees, the company focuses its efforts on developing groundbreaking solutions for global health challenges. Ennaid Therapeutics specializes in the research and development of therapeutic cures for diseases caused by mosquito-borne viruses. Their primary focus is on developing treatments for Zika Virus, a global pandemic that has affected millions worldwide. The company distinguishes itself by pursuing a therapeutic cure approach rather than traditional vaccine development. This innovative approach aims to provide a comprehensive solution for combating Zika Virus and its potentially debilitating long-term effects. For more information about Ennaid Therapeutics and their research, visit ennaidthera.com.